596057 Disclosed is a pharmaceutical composition comprising an anabolic steroid (such as oxymetholone oxandrolone nandrolone and esters thereof such as nandrolone decanoate) and a vitamin D compound (such as ergocalciferol cholecalciferol calcidiol calcitriol doxercalciferol or calcipotriene) in a carrier liquid wherein the composition is adapted for parenteral administration. Further disclosed is the use of an anabolic steroid and a vitamin D compound in the manufacture of a parenteral composit...

The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which compr...

The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which compr...

The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which compr...

The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which compr...

The present invention relates to a process for the synthesis of oxandrolone from mestanolone. The process comprises the steps of: (a) oxidizing mestanolone to form 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one; (b) hydroxylating the 17β-hydroxy-17α-methyl-5α-androst-1-en-3-one to form 1α 2α 17β-trihydroxy-17α-methylandrostan-3-one; (c) cleaving the 1α 2α 17β-trihydroxy-17α-methylandrostan-3-one to form 17β-h...

The present invention relates to a process for the synthesis of oxandrolone from mestanolone. The process comprises the steps of: (a) oxidizing mestanolone to form 17?-hydroxy-17?-methyl-5?-androst-1-en-3-one; (b) hydroxylating the 17?-hydroxy-17?-methyl-5?-androst-1-en-3-one to form 1?2? 17?-trihydroxy-17?-methylandrostan-3-one; (c) cleaving the 1? 2? 17?-trihydroxy-17?methylandrostan-3-one to form 17?-hydroxy-17?-methyl-1-oxo-12-seco-A-nor-5?androstan-2-oic acid; and (d) reducing the 17?-hydro...

The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which compr...

The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient suffering from a wound which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The subject invention further provides a method of treating burn-induced weight loss in a burn patient which compr...

The present invention relates to a process for the synthesis of oxandrolone from mestanolone. The process comprises the steps of: (a) oxidizing mestanolone to form 17β -hydroxy-17α -methyl-5 -androst-1-en-3-one; (b) hydroxylating the 17β - hydroxy-17α -methyl-5α -androst-1-en-3-one to form 1α 2α 17β -trihydroxy-17α - methylandrostan-3-one; (c) cleaving the 1α 2α 17β -trihydroxy-17α -methylandrostan-3- one to form 17β -hydroxy-17α -methyl-1-oxo-12-seco-A-nor-5 -androstan-2-oic acid; and (d) r...